Stay updated with breaking news from Christopher Damman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Because the lower part of the gut makes hormones, among them GLP-1, that help orchestrate metabolism and appetite, giving microbes the right fuel through food can stimulate the gut to make them.
Wegovy, Ozempic and Mounjaro are weight loss and diabetes drugs that have made quite a splash in health news. They target regulatory pathways involved in both obesity and diabetes and
Weight loss and diabetes drugs target regulatory pathways involved in metabolism that the microbes in your gut and certain molecules from food already play a key role in regulating.
GLP-1 drugs like Ozempic and Wegovy have garnered consumer attention for their ability to curb unhealthy food and beverage cravings, leading to weight loss, as large CPG companies and major retailers might be able to use the moment to refocus on providing better-for-you and healthier options.
Browse Chronic diseases news, research and analysis from The Conversation